Related Experiment Video
Updated: Apr 30, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis
Objective:
To determine the characteristics of pulmonary tuberculosis (TB) patients harbored organisms with isoniazid mono-resistant drug susceptibility pattern.
Material And Method:
A retrospective review of medical records for all culture-proven adult pulmonary TB patients in Siriraj Hospital between July 2009 and July 2011 was conducted. Demographic data, clinical presentations, and radiological characteristics were recorded and compared between isoniazid mono-resistant and other-resistant groups. Treatment regimens with outcome determination of patients infected with isoniazid mono-resistant strains were also verified.
Results:
Among 489 patients during the present study period, 28 were infected with isoniazid mono-resistant strain (5.7%). The mean age was 53 +/- 18 years, and 8% of them had a history of previous treatment in the past. When compared with those infected with any other form of resistant strains, isoniazid mono-resistant pulmonary TB patients tended to have less radiographic cavitary lesion (8.3% vs. 26.7%, p = 0.006) but no significant difference was seen in term of demographic data and clinical presentations. All of them who had completed the treatment were cured. No difference in cure rate and relapse rate among patients treated with quinolone or non-quinolone containing regimens.
Conclusion:
Isoniazid mono-resistance shares common clinical features with other resistances pulmonary TB, except for less cavitary lesion from initial chest radiograph. Appropriate drug susceptibility testing with prompt regimen adjustment can lead to a favorable treatment outcome.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atypical Pneumonia
